Logan Zemp

发表

Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity.

J. Pow-Sang, J. Chahoud, A. Hajiran, 2020, Urologic oncology.

Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma

R. Dunn, Jingsong Zhang, P. Spiess, 2022, JAMA network open.

Contemporary management of early stage testicular seminoma.

W. Sexton, P. Johnstone, A. Aydin, 2020, Translational andrology and urology.

Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer.

Jingsong Zhang, P. Spiess, W. Sexton, 2022, Urologic oncology.

Geospatial Cellular Distribution of Cancer-Associated Fibroblasts Significantly Impacts Clinical Outcomes in Metastatic Clear Cell Renal Cell Carcinoma

Gregory J. Kimmel, P. Spiess, J. Mulé, 2021, Cancers.

Preoperative pad usage is independently associated with failure of non-adjustable male trans-obturator slings in otherwise well-selected patients.

K. Rourke, Logan Zemp, N. Hoy, 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Perinephric Hematoma Size is Independently Associated with the Need for Urological Intervention in Multisystem Blunt Renal Trauma

K. Rourke, Logan Zemp, U. Mann, 2018, The Journal of urology.

Trauma / Reconstruction / Diversion Perinephric Hematoma Size is Independently Associated with the Need for Urological Intervention in Multisystem Blunt Renal Trauma

K. Rourke, Logan Zemp, U. Mann, 2018 .

The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures

J. Mulé, A. Berglund, Roger Li, 2021, Frontiers in Immunology.

Pathologic and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed with Cystectomy with or Without Neoadjuvant Chemotherapy.

W. Sexton, Roger Li, B. Manley, 2020, The Journal of urology.

Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma.

W. Fan, P. Spiess, J. Mulé, 2021, European urology focus.

Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?

P. Spiess, Jiannong Li, J. Chahoud, 2021, Frontiers in Oncology.

Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response

P. Spiess, W. Sexton, J. Mulé, 2020, Clinical and experimental immunology.

Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma

Gregory J. Kimmel, P. Spiess, J. Mulé, 2021, bioRxiv.

Contemporary management of renal trauma in Canada: A 10-year experience at a level 1 trauma centre.

K. Rourke, Logan Zemp, U. Mann, 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension

W. Sexton, R. Jain, S. Gilbert, 2023, Current oncology.

Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma

Jingsong Zhang, P. Spiess, W. Sexton, 2021, JAMA network open.

Comparative effectiveness analysis of first-line immunotherapy versus chemotherapy in metastatic urothelial carcinoma of the bladder.

Jingsong Zhang, W. Sexton, Roger Li, 2021, Urologic oncology.

Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer

Jingsong Zhang, W. Sexton, Roger Li, 2021, The Journal of urology.

Impact of surgical margin and extent of lymphadenectomy on oncologic outcomes in plasmacytoid urothelial carcinoma.

W. Sexton, R. Jain, S. Gilbert, 2023, Urologic oncology.

Leveraging innovative therapies with an evolving understanding of the molecular pathogenesis of penile squamous cell carcinoma.

P. Spiess, A. Hajiran, Logan Zemp, 2020, Urologic oncology.

Mobile Postoperative Symptom Intervention Tool and Biometric Monitoring After Radical Cystectomy: Pilot Study Evaluating Feasibility, Usability, and Potential Utility

H. Jim, B. Gonzalez, Kea Turner, 2022, The Journal of urology.

Clinical indications for necessary and discretionary hospital readmissions after radical cystectomy.

W. Sexton, Roger Li, S. Gilbert, 2021, Urologic oncology.

Will Dynamic Sentinel Lymph Node Biopsy Surpass Inguinal Lymph Node Dissection in High-risk Node-negative Penile Cancer?

Taylor C Peak, Logan Zemp, Philippe E. Spiess, 2022, European Urology Oncology.

The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features.

J. Raman, S. Matin, V. Master, 2023, European urology oncology.

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals

S. Matin, V. Master, W. Sexton, 2023, European urology open science.

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.

S. Matin, V. Master, W. Sexton, 2023, European Urology.

Contemporary patients have better perioperative outcomes following cytoreductive nephrectomy: a multi-institutional analysis of 1272 consecutive patients.

C. Wood, J. Raman, S. Matin, 2023, Urology.

Management of Bulky Inguinal and Pelvic Lymph Nodes

Logan Zemp, Jan K. Rudzinski, Curtis A. Pettaway, 2024, Urologic Clinics of North America.

Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma.

W. Sexton, J. Chahoud, J. Dhillon, 2024, Laboratory investigation; a journal of technical methods and pathology.

From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer.

W. Sexton, M. Poch, A. Vosoughi, 2024, Current oncology reports.

MP39-14 IDENTIFICATION OF RECURRENT SOMATIC SPLICE SITE VARIANTS ACROSS MULTIPLE CLEAR CELL RENAL CELL CARCINOMA COHORTS

J. Chahoud, A. Hajiran, N. Chakiryan, 2021 .